Go to The Journal of Clinical Investigation
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
  • Physician-Scientist Development
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Immunology
    • Metabolism
    • Nephrology
    • Oncology
    • Pulmonology
    • All ...
  • Videos
  • Collections
    • In-Press Preview
    • Resource and Technical Advances
    • Clinical Research and Public Health
    • Research Letters
    • Editorials
    • Perspectives
    • Physician-Scientist Development
    • Reviews
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • In-Press Preview
  • Resource and Technical Advances
  • Clinical Research and Public Health
  • Research Letters
  • Editorials
  • Perspectives
  • Physician-Scientist Development
  • Reviews
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
Induced regulatory T cells in allograft tolerance via transient mixed chimerism
Kiyohiko Hotta, … , A. Benedict Cosimi, Tatsuo Kawai
Kiyohiko Hotta, … , A. Benedict Cosimi, Tatsuo Kawai
Published July 7, 2016
Citation Information: JCI Insight. 2016;1(10):e86419. https://doi.org/10.1172/jci.insight.86419.
View: Text | PDF
Research Article Immunology Transplantation

Induced regulatory T cells in allograft tolerance via transient mixed chimerism

  • Text
  • PDF
Abstract

Successful induction of allograft tolerance has been achieved in nonhuman primates (NHPs) and humans via induction of transient hematopoietic chimerism. Since allograft tolerance was achieved in these recipients without durable chimerism, peripheral mechanisms are postulated to play a major role. Here, we report our studies of T cell immunity in NHP recipients that achieved long-term tolerance versus those that rejected the allograft (AR). All kidney, heart, and lung transplant recipients underwent simultaneous or delayed donor bone marrow transplantation (DBMT) following conditioning with a nonmyeloablative regimen. After DBMT, mixed lymphocyte culture with CFSE consistently revealed donor-specific loss of CD8+ T cell responses in tolerant (TOL) recipients, while marked CD4+ T cell proliferation in response to donor antigens was found to persist. Interestingly, a significant proportion of the proliferated CD4+ cells were FOXP3+ in TOL recipients, but not in AR or naive NHPs. In TOL recipients, CD4+FOXP3+ cell proliferation against donor antigens was greater than that observed against third-party antigens. Finally, the expanded Tregs appeared to be induced Tregs (iTregs) that were converted from non-Tregs. These data provide support for the hypothesis that specific induction of iTregs by donor antigens is key to long-term allograft tolerance induced by transient mixed chimerism.

Authors

Kiyohiko Hotta, Akihiro Aoyama, Tetsu Oura, Yohei Yamada, Makoto Tonsho, Kyu Ha Huh, Kento Kawai, David Schoenfeld, James S. Allan, Joren C. Madsen, Gilles Benichou, Rex-Neal Smith, Robert B. Colvin, David H. Sachs, A. Benedict Cosimi, Tatsuo Kawai

×

Figure 8

Peripheral blood lymphocytes of the tolerant recipients primed with donor antigens suppressed T cell activation.

Options: View larger image (or click on image) Download as PowerPoint
Peripheral blood lymphocytes of the tolerant recipients primed with dono...
Peripheral blood lymphocytes (PBLs) from 3 recipients ,M8907: d821 pBMT (A), M6007: d930 pBMT (B), and M8314: d261 pBMT (C), in the tolerant (TOL) group were labeled with CFSE and cultured with irradiated donor or third-party PBLs. After 5 days of culture, CD4+CSFElow (proliferating) and CD4+CSFEhigh (nonproliferating) cells were sorted and added at a varying ratio into the recipient T cells in the presence of CD3/CD28 bead stimulation. (A and B) A dose-dependent suppression of T cell activation was observed by donor-primed proliferating (CSFElow) cells in both recipients. Although less significant, third-party-primed proliferating cells of a recipient (M8907) also showed a dose-dependent suppression of T cell activation (A). However, such a dose-dependent suppression by the third-party-primed cells was not observed in the other recipient (M6007) (B). Nonproliferating cells primed with either donor or third-party antigens failed to suppress T cell activation. (C) To evaluate whether this suppressive function of the donor-primed CD4+ proliferating cells depends on cell-to-cell contact, isolated CD3+ cells from a TOL recipient (M8314) stained with CFSE were cultured with CD3/CD28 beads. Donor-primed proliferating CD4+ (CSFElow) cells were added directly (contact) or seeded onto Transwell permeable support cell culture inserts (no contact). Since CD4+ cells consisted of both responder CD4+ cells and modulator CD4+ cells in this experiment, T cell activation was evaluated by CD8+ cell proliferation. The ratio of responder to modulator was 1 to 1. Although inhibition of CD8+ cell activation was observed by cell-to-cell contact, such inhibition was not observed in the Transwell system, which suggested that direct cell-to-cell contact is required for suppressive function of donor-primed modulator cells. pBMT, post bone marrow transplantation.

Copyright © 2025 American Society for Clinical Investigation
ISSN 2379-3708

Sign up for email alerts